Zobrazeno 1 - 10 of 12 pro vyhledávání: '"B. Woun Seo"'
2
PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
Autor: Ronald Swerdloff, Christina Wang, Marc Gittelman, Jay Newmark, B Woun Seo, Nestor Rohowsky, Robert Dudley
Publikováno v: Journal of the Endocrine Society. 6:A704-A705
In 2019, a novel, first-in-class testosterone (T) replacement therapy (TRT), oral testosterone undecanoate (TU) was approved by the U.S. FDA for the treatment of male hypogonadism. During clinical trials, dose adjustments were based on 24-hr average
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c1421f6be070e70a70b3de03821cae5
https://doi.org/10.1210/jendso/bvac150.1452
Zobrazit plný text záznamu
3
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety
Autor: Stanton Honig, Marc Gittelman, Jed Kaminetsky, Christina Wang, John K. Amory, Nestor Rohowsky, Robert E. Dudley, B. Woun Seo, Jay Newmark, Ronald Swerdloff
Publikováno v: The journal of sexual medicine. 19(12)
Background Long-term data evaluating the efficacy and safety of oral testosterone undecanoate (oral TU; JATENZO) in adult hypogonadal men provides important information for healthcare professionals who prescribe testosterone replacement therapy (TRT)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3f0bba14691a7d17c5b874262852e5
https://pubmed.ncbi.nlm.nih.gov/36272969
Zobrazit plný text záznamu
5
PD20-07 SAFETY ANALYSIS OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION FOLLOWING 2 YEARS OF ADMINISTRATION IN HYPOGONADAL MEN
Autor: Nestor Rohowsky, Ronald S. Swerdloff, Christina Yan Wang, Marc Gittelman, Parviz K. Kavoussi, B. Woun Seo, Robert E Dudley
Publikováno v: Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:An oral testosterone (T) replacement therapy (TRT) would be the preferred administration route for many hypogonadal men. Until recently, the only oral TRT approved in the...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbc74cba8be1bb9e1f4cbf791dd51c96
https://doi.org/10.1097/ju.0000000000002009.07
Zobrazit plný text záznamu
9
Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis
Autor: Shufang Liu, Suzanne H. Michel, Rupal Khurmi, Mudra Kapoor, Michael S. Schechter, B Woun Seo, Mark Haupt
Publikováno v: Journal of Pediatric Gastroenterology and Nutrition
Objective: The aim of the study is to test the hypothesis of a positive relationship between initial dose of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) and optimal weight gain over the first 2 years of life. Met
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c961d0b6bc0c034a5b2e1bf9a2273f54
https://pubmed.ncbi.nlm.nih.gov/30052568
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje